Chimeric contribution of human extended pluripotent stem cells to monkey embryos ex vivo
نویسندگان
چکیده
(Cell 184, 2020–2032.e1–e14; April 15, 2021) In the original version of this paper, we failed to include in author list Hongkui Deng, who made a critical contribution work by providing extended pluripotent stem cells. The online paper has been corrected. All co-authors have approved addition. We also cited preliminary manuscript deposited on bioRxiv (Aksoy et al., 2020) instead published study 2021Aksoy I. Rognard C. Moulin A. Marcy G. Masfaraud E. Wianny F. Cortay V. Bellemin-Ménard Doerflinger N. Dirheimer M. al.Apoptosis, G1 Phase Stall, and Premature Differentiation Account for Low Chimeric Competence Human Rhesus Monkey Naive Pluripotent Stem Cells.Stem Cell Reports. 2021; 16: 56-74Abstract Full Text PDF PubMed Scopus (12) Google Scholar; full citation below). This corrected online. apologize any confusion these errors may caused. human cells monkey embryos ex vivoTan al.CellApril 2021In BriefHuman cells, form ability contribute both embryonic extra-embryonic lineages ex-vivo-cultured embryos. Full-Text Open Archive
منابع مشابه
X-chromosome inactivation in monkey embryos and pluripotent stem cells.
Inactivation of one X chromosome in female mammals (XX) compensates for the reduced dosage of X-linked gene expression in males (XY). However, the inner cell mass (ICM) of mouse preimplantation blastocysts and their in vitro counterparts, pluripotent embryonic stem cells (ESCs), initially maintain two active X chromosomes (XaXa). Random X chromosome inactivation (XCI) takes place in the ICM lin...
متن کاملContribution of Mouse Embryonic Stem Cells and Induced Pluripotent Stem Cells to Chimeras through Injection and Coculture of Embryos
Blastocyst injection and morula aggregation are commonly used to evaluate stem cell pluripotency based on chimeric contribution of the stem cells. To assess the protocols for generating chimeras from stem cells, 8-cell mouse embryos were either injected or cocultured with mouse embryonic stem cells and induced pluripotent stem cells, respectively. Although a significantly higher chimera rate re...
متن کاملAn ex vivo Gene Therapy Approach to Treat Muscular Dystrophy Using inducible Pluripotent Stem Cells
Duchenne muscular dystrophy is a progressive and incurable neuromuscular disease caused by genetic and biochemical defects of the dystrophin-glycoprotein complex. Here we show the regenerative potential of myogenic progenitors derived from corrected dystrophic induced pluripotent stem cells generated from fibroblasts of mice lacking both dystrophin and utrophin. We correct the phenotype of dyst...
متن کاملEx vivo expansion of human hematopoietic stem and progenitor cells.
Despite progress in our understanding of the growth factors that support the progressive maturation of the various cell lineages of the hematopoietic system, less is known about factors that govern the self-renewal of hematopoietic stem and progenitor cells (HSPCs), and our ability to expand human HSPC numbers ex vivo remains limited. Interest in stem cell expansion has been heightened by the i...
متن کاملEx vivo expansion of human hematopoietic stem cells.
There has been great interest in the ex vivo expansion of human long-term repopulating hematopoietic stem cells (LTR-HSCs) for a variety of clinical applications such as umbilical cord blood transplantation. The glucoprotein130 signal, activated by a complex of interleukin 6 (IL-6) and soluble IL-6 receptor (IL-6/sIL-6R), acts dramatically in synergy with the c-Kit or Flk2/Flt3 signal to expand...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cell
سال: 2021
ISSN: ['0092-8674', '1097-4172']
DOI: https://doi.org/10.1016/j.cell.2021.06.011